Curran M. Simpson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Curran M. Simpson
Curran M. Simpson is recorded as Board Member, CEO and COO at REGENXBIO Inc. (RGNX). REGENXBIO Inc. reported in an 8-K filed June 13, 2024 that Curran M. Simpson was appointed Class I director, effective July 1, 2024. REGENXBIO Inc. reported in an 8-K filed June 13, 2024 that Curran M. Simpson was appointed President and Chief Executive Officer, effective July 1, 2024. REGENXBIO Inc. reported in an 8-K filed January 10, 2023 that Curran M. Simpson was appointed Chief Operating Officer, effective January 9, 2023.
“In connection with his appointment, the Board appointed Mr. Simpson as a Class I director, effective July 1, 2024, with a term expiring at the Company's 2025 annual meeting of stockholders or until such time as his successor is duly elected and qualified.”
“The Company also announced that the Board appointed Curran M. Simpson as President and Chief Executive Officer, effective as of July 1, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-07-01–present
-
Current
2024-07-01–present
-
Current
2023-01-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at REGENXBIO Inc.
Other people whose current roles at this company are on record from its filings.
- Allan M. Fox Chairman, Board Member
- Kenneth T. Mills Chairman, Board Member
- Former EVP CFO
- Mitchell Chan Chief Accounting Officer
- Alexandra Glucksmann Board Member
- Alexandra Glucksmann, Ph.D. Board Member
- Curran Simpson Board Member
- Daniel Tassé Board Member
- David Stump Board Member
- George Migausky Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.